Traders bought shares of C.R. Bard Inc. (NYSE:BCR) on weakness during trading hours on Monday. $44.48 million flowed into the stock on the tick-up and $18.05 million flowed out of the stock on the tick-down, for a money net flow of $26.43 million into the stock. Of all stocks tracked, C.R. Bard had the 11th highest net in-flow for the day. C.R. Bard traded down ($1.83) for the day and closed at $237.17

Several equities research analysts have recently issued reports on the stock. Bank of America Corp. lowered shares of C.R. Bard from a “buy” rating to a “neutral” rating in a research note on Friday. Leerink Swann reissued a “hold” rating on shares of C.R. Bard in a research note on Wednesday, May 25th. Piper Jaffray Cos. reissued a “buy” rating and set a $241.00 target price on shares of C.R. Bard in a research note on Tuesday, May 24th. Needham & Company LLC reissued a “hold” rating on shares of C.R. Bard in a research note on Tuesday, May 24th. Finally, Barclays PLC increased their target price on shares of C.R. Bard from $212.00 to $224.00 and gave the stock an “equal weight” rating in a research note on Tuesday, May 24th. Ten analysts have rated the stock with a hold rating and five have given a buy rating to the company. The stock has a consensus rating of “Hold” and an average target price of $220.13.

The company’s 50 day moving average price is $226.82 and its 200-day moving average price is $204.30. The firm has a market capitalization of $17.39 billion and a P/E ratio of 160.36.

C.R. Bard (NYSE:BCR) last released its earnings results on Wednesday, April 27th. The company reported $2.34 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.17 by $0.17. During the same period in the previous year, the business posted $2.10 EPS. The company had revenue of $873.50 million for the quarter, compared to analyst estimates of $845.77 million. The firm’s quarterly revenue was up 6.6% on a year-over-year basis. Analysts expect that C.R. Bard Inc. will post $10.15 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, July 29th. Shareholders of record on Monday, July 18th will be paid a dividend of $0.26 per share. The ex-dividend date is Thursday, July 14th. This is an increase from C.R. Bard’s previous quarterly dividend of $0.24. This represents a $1.04 annualized dividend and a yield of 0.44%.

In other news, CFO Christopher S. Holland sold 3,970 shares of the firm’s stock in a transaction dated Friday, May 27th. The shares were sold at an average price of $219.89, for a total transaction of $872,963.30. Following the completion of the transaction, the chief financial officer now owns 31,306 shares in the company, valued at approximately $6,883,876.34. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, VP Sharon M. Luboff sold 10,000 shares of the firm’s stock in a transaction dated Wednesday, April 27th. The shares were sold at an average price of $210.00, for a total transaction of $2,100,000.00. Following the transaction, the vice president now owns 33,706 shares of the company’s stock, valued at approximately $7,078,260. The disclosure for this sale can be found here.

Several institutional investors have bought and sold shares of BCR. Marshall Wace LLP raised its position in C.R. Bard by 155.1% in the fourth quarter. Marshall Wace LLP now owns 375,232 shares of the company’s stock valued at $71,084,000 after buying an additional 228,166 shares during the period. Vanguard Group Inc. raised its position in C.R. Bard by 1.7% in the fourth quarter. Vanguard Group Inc. now owns 6,843,224 shares of the company’s stock valued at $1,296,380,000 after buying an additional 116,588 shares during the period. Bank of Montreal Can raised its position in C.R. Bard by 58.3% in the fourth quarter. Bank of Montreal Can now owns 166,831 shares of the company’s stock valued at $31,604,000 after buying an additional 61,469 shares during the period. Stevens Capital Management LP acquired a new position in C.R. Bard during the fourth quarter valued at $5,131,000. Finally, State of Wisconsin Investment Board raised its position in C.R. Bard by 18.1% in the fourth quarter. State of Wisconsin Investment Board now owns 94,995 shares of the company’s stock valued at $17,996,000 after buying an additional 14,530 shares during the period.

C. R. Bard, Inc (Bard) and its subsidiaries are engaged in designing, manufacturing, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. The Company sells its products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.